Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of minimal residual disease in leukemias: a critical approach.

Nouvelle revue francaise d'hematologie - 1 Jan 1990

Baruchel A, Schaison G

Abstract excerpt

The detection of minimal residual disease (MRD) represents a major goal in leukemias with great potential applications: identification of patients at high risk of relapse, earlier detection of relapses, possible improvement of autologous bone marrow transplantation (determination of the best time for bone marrow harvest and assessment of its quality). Theoretical requirements for a model of MRD detection exist...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, ras
Share to Antibodies, Monoclonal
Share to Gene Rearrangement

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Karyotyping

Share to Models, Biological

Share to Mutation

Share to Polymerase Chain Reaction

Share to Risk Factors

Source

Identifiers

PMID: 2190175

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of minimal residual disease in leukemias: a critical approach.PMID 2190175Read ↗

A look into the future: can minimal residual disease guide therapy and predict prognosis in chronic lymphocytic leukemia?Semantic proximity Read ↗

Detection of minimal residual disease in acute myelogenous leukemia.Semantic proximity Read ↗

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologiesSemantic proximity Read ↗

Minimal residual disease: optimal methods, timing, and clinical relevance for an individual patientSemantic proximity Read ↗

Detection and management of minimal residual disease in acute lymphoblastic leukemiaSemantic proximity Read ↗

Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for “prime time”?Semantic proximity Read ↗

MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.Semantic proximity Read ↗

Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemiaSemantic proximity Read ↗

Minimal residual disease in acute myeloid leukemia: coming of age.Semantic proximity Read ↗

Current strategies for detection and approach to measurable residual disease in acute myeloid leukemia.Semantic proximity Read ↗

The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.Semantic proximity Read ↗

[Minimal residual disease in acute lymphoblastic leukemia: a new concept of complete remission].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.